Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3561 Target Snapshot

Gamma-aminobutyric acid receptor subunit rho-1 · SINGLE PROTEIN · Homo sapiens

135Compounds
47Assays
2Approved Drugs
139.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P24046. Use UniProt P24046 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P24046 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Gamma-aminobutyric acid receptor subunit rho-1 as ChEMBL target CHEMBL3561, mapped to UniProt P24046. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Gamma-aminobutyric acid receptor subunit rho-1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL3561
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P24046
Gamma-aminobutyric acid receptor subunit rho-1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Gamma-aminobutyric acid receptor subunit rho-1 is the right protein anchor across sources, using UniProt P24046 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelGamma-aminobutyric acid receptor subunit rho-1
UniProt AccessionP24046
Component TypeProtein
Sequence Length479 aa

Gamma-aminobutyric acid receptor subunit rho-1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Gamma-aminobutyric acid receptor subunit rho-1, mapped to UniProt P24046. Sequence length is 479 aa.

Mapped IDP24046
Review nameGamma-aminobutyric acid receptor subunit rho-1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase II
3
Phase I
Assay Mix

Activity Type Distribution

IC5036.0
EC50102.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL15891 7.04 IC50 91.0 Approved
CHEMBL96 6.57 EC50 269.15 Preclinical
CHEMBL33086 6.4 EC50 400.0 Preclinical
CHEMBL273481 6.16 EC50 691.83 Preclinical
CHEMBL1890408 6.1 IC50 800.0 Preclinical
CHEMBL4464494 5.92 EC50 1200.0 Preclinical
CHEMBL3322882 5.91 EC50 1230.27 Preclinical
CHEMBL3322886 5.8 EC50 1584.89 Preclinical
CHEMBL4442696 5.8 EC50 1584.89 Preclinical
CHEMBL397209 5.65 IC50 2220.0 Preclinical
Distribution

pChEMBL Value Distribution

22
5.0
18
5.5
12
6.0
4
6.5
1
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

LINDANE
CHEMBL15891
Approved 1974
Assay Landscape

Assay Landscape

47
Total Assays
39
Tested Compounds
2
Assay Types
Binding — 28 assays, 39 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 20 19 5.4
single protein format 4 7 5.6
assay format 2 8 4.8
cell membrane format 2 5 5.7
Functional — 19 assays, 25 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 17 25 5.0
assay format 2 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine